Axon Enterprise, Inc (NASDAQ:AXON) Position Increased by Decker Retirement Planning Inc.

Decker Retirement Planning Inc. grew its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 22.6% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 6,156 shares of the biotechnology company's stock after buying an additional 1,133 shares during the period. Axon Enterprise makes up about 2.0% of Decker Retirement Planning Inc.'s investment portfolio, making the stock its 9th largest holding. Decker Retirement Planning Inc.'s holdings in Axon Enterprise were worth $3,238,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. Kentucky Retirement Systems Insurance Trust Fund bought a new position in Axon Enterprise during the first quarter valued at approximately $1,110,000. CX Institutional bought a new position in Axon Enterprise during the first quarter valued at approximately $115,000. Blue Trust Inc. lifted its position in Axon Enterprise by 33.1% during the first quarter. Blue Trust Inc. now owns 169 shares of the biotechnology company's stock valued at $89,000 after purchasing an additional 42 shares during the period. Xponance Inc. lifted its position in Axon Enterprise by 3.5% during the fourth quarter. Xponance Inc. now owns 16,469 shares of the biotechnology company's stock valued at $9,788,000 after purchasing an additional 560 shares during the period. Finally, Brighton Jones LLC bought a new position in Axon Enterprise during the fourth quarter valued at approximately $480,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CEO Patrick W. Smith sold 10,000 shares of the firm's stock in a transaction dated Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the sale, the chief executive officer now directly owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. This trade represents a 0.33% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Joshua Isner sold 905 shares of the firm's stock in a transaction dated Tuesday, June 17th. The shares were sold at an average price of $776.39, for a total transaction of $702,632.95. Following the completion of the sale, the president now owns 268,735 shares in the company, valued at $208,643,166.65. This represents a 0.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 44,642 shares of company stock valued at $30,500,428 in the last 90 days. Company insiders own 5.70% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on AXON shares. The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. Barclays upped their target price on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. Bank of America upped their target price on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research report on Wednesday, June 4th. Needham & Company LLC upped their target price on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a research report on Thursday, May 8th. Finally, Craig Hallum downgraded shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $699.55.

Axon Enterprise Trading Up 1.8%

AXON stock traded up $14.65 during midday trading on Friday, reaching $818.60. The company's stock had a trading volume of 1,010,596 shares, compared to its average volume of 534,909. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.62 and a current ratio of 2.83. The stock has a fifty day simple moving average of $714.97 and a two-hundred day simple moving average of $630.47. Axon Enterprise, Inc has a 1 year low of $279.02 and a 1 year high of $820.83. The firm has a market capitalization of $63.73 billion, a price-to-earnings ratio of 502.21, a PEG ratio of 94.23 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, topping the consensus estimate of $1.34 by $0.07. The company had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The firm's revenue was up 31.3% compared to the same quarter last year. During the same quarter last year, the firm posted $1.15 EPS. On average, equities research analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.